Shares of Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $18.37, but opened at $19.96. Ascentage Pharma Group International shares last traded at $20.05, with a volume of 23,192 shares trading hands.
Analyst Upgrades and Downgrades
Separately, JPMorgan Chase & Co. began coverage on shares of Ascentage Pharma Group International in a report on Thursday. They issued an “overweight” rating on the stock.
View Our Latest Research Report on Ascentage Pharma Group International
Ascentage Pharma Group International Stock Performance
About Ascentage Pharma Group International
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Further Reading
- Five stocks we like better than Ascentage Pharma Group International
- How is Compound Interest Calculated?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- What is the Hang Seng index?
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
